Evans Daron (CIK 0001411726)

Latest company ownership

Shares held
1,058,896
Last filed at
Apr 2, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2008Q2 2025Q4
Shares held
92,000
Last filed at
Nov 21, 2025
Confidence Score
89.5
2025Q4
Confidence Score History
2024Q1 2025Q4
NEPH - NEPHROS INC
Role: CEO
Shares held
8,669
Last filed at
Jun 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 15, 2025 Rezolute, Inc. CFO Buy 90.0 +45,000 9.62% ✗ $79.6K
Jun 24, 2025 Jun 24, 2025 Rezolute, Inc. CFO Buy 78.8 +5,000 1.40% ✗ $20.3K
Mar 26, 2025 Mar 28, 2025 Rezolute, Inc. CFO Buy 90.0 +20,000 6.45% ✗ $57.7K
Dec 18, 2024 Dec 18, 2024 Rezolute, Inc. CFO Buy 83.8 +10,000 4.49% ✗ $42.9K
Dec 12, 2024 Dec 12, 2024 Rezolute, Inc. CFO Buy 83.8 +9,000 4.21% ✗ $41.4K
Dec 9, 2025 Dec 10, 2024 Rezolute, Inc. CFO Buy 90.0 +10,549 5.19% ✗ $53.2K
Jun 14, 2024 Jun 14, 2024 Rezolute, Inc. CFO Buy 95.0 +40,000 24.49% ✗ $161.6K
May 29, 2024 May 31, 2024 Rezolute, Inc. CFO Buy 60.0 +451 0.28% ✗ $1.6K
May 23, 2024 May 28, 2024 Rezolute, Inc. CFO Buy 77.5 +3,000 1.88% ✗ $9.7K
Mar 15, 2024 Mar 19, 2024 Rezolute, Inc. CFO Buy 91.3 +20,000 14.30% ✗ $33.8K
Mar 8, 2024 Mar 8, 2024 Rezolute, Inc. CFO Buy 95.0 +50,000 55.62% ✗ $96.3K
Feb 16, 2024 Feb 20, 2024 Rezolute, Inc. CFO Buy 95.0 +50,900 130.51% ✗ $66.7K
May 27, 2021 Jun 1, 2021 NEPHROS INC CEO Sell 27.5 -698 -3.81% ✗ $1.9K
Mar 12, 2020 Mar 12, 2020 NEPHROS INC CEO Buy 78.8 +2,500 1.61% ✗ $16.6K
Mar 5, 2020 Mar 5, 2020 NEPHROS INC CEO Buy 78.8 +2,500 1.63% ✗ $21.1K
Nov 18, 2019 Nov 18, 2019 NEPHROS INC CEO Buy 67.5 +1,000 0.70% ✗ $8.4K
Aug 22, 2019 Aug 22, 2019 NEPHROS INC CEO Buy 78.8 +2,000 1.42% ✗ $13.8K
Jun 14, 2019 Jun 14, 2019 NEPHROS INC CEO Buy 83.8 +43,172 3.52% ✗ $25.8K
Apr 10, 2018 Apr 12, 2018 NEPHROS INC CEO Buy 86.3 +79,000 7.92% ✗ $35.6K
Sep 5, 2017 Sep 6, 2017 NEPHROS INC CEO Buy 82.5 +29,580 3.75% ✗ $7.2K
Aug 22, 2017 Aug 23, 2017 NEPHROS INC CEO Buy 67.5 +4,000 0.51% ✗ $1K
Aug 11, 2017 Aug 11, 2017 NEPHROS INC CEO Buy 86.3 +70,000 9.80% ✗ $18.2K
Jun 12, 2017 Jun 13, 2017 NEPHROS INC CEO Buy 82.5 +21,461 3.10% ✗ $5.6K
May 18, 2017 May 19, 2017 NEPHROS INC CEO Buy 82.5 +30,000 4.53% ✗ $7.7K
Dec 7, 2016 Dec 9, 2016 NEPHROS INC CEO Buy 77.5 +4,069 1.21% ✗ $1.3K
Dec 5, 2016 Dec 6, 2016 NEPHROS INC CEO Buy 82.5 +10,620 3.27% ✗ $3.6K
Nov 30, 2016 Dec 2, 2016 NEPHROS INC CEO Buy 91.3 +41,530 14.66% ✗ $13.3K
Aug 27, 2015 Aug 31, 2015 NEPHROS INC CEO Buy 91.3 +44,175 35.18% ✗ $25.3K
Aug 19, 2015 Aug 20, 2015 NEPHROS INC CEO Buy 91.3 +51,500 69.52% ✗ $27.4K
Dec 18, 2014 Dec 22, 2014 NEPHROS INC Director Buy 91.3 +21,239 40.19% ✗ $12.7K
Mar 21, 2014 Mar 27, 2014 NEPHROS INC Director Buy 90.0 +2,151 28.68% ✗ $645.3
Mar 11, 2009 Mar 13, 2009 CAPRICOR THERAPEUTICS, INC. CFO Buy 90.0 +11,000 125.00% ✗ $8.4K
Dec 12, 2008 Dec 12, 2008 CAPRICOR THERAPEUTICS, INC. CFO Buy 90.0 +4,186 90.72% ✗ $3.5K
Dec 11, 2008 Dec 12, 2008 CAPRICOR THERAPEUTICS, INC. CFO Buy 90.0 +3,814 476.75% ✗ $2.9K
Apr 14, 2008 Apr 16, 2008 CAPRICOR THERAPEUTICS, INC. CFO Buy 90.0 +800 100.00% ✗ $3.6K